Level Bio AB (XSAT:LEVBIO) Debt-to-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB Debt-to-Asset?

Level Bio AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Level Bio AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Level Bio AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was kr15.74 Mil. Level Bio AB's debt to asset for the quarter that ended in Mar. 2024 was 0.00.

Level Bio AB Debt-to-Asset Historical Data

The historical data trend for Level Bio AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB Debt-to-Asset Chart

Level Bio AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.27

0.12

0.03

0.02

0.06

Level Bio AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															-	-	-	0.06	-

Competitive Comparison of Level Bio AB's Debt-to-Asset

For the Diagnostics & Research subindustry, Level Bio AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Level Bio AB's Debt-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Level Bio AB's Debt-to-Asset falls into.

Level Bio AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Level Bio AB's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.107	+	0)	/	19.093
	=	0.06

Level Bio AB's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	15.737
	=	0.00

Level Bio AB (XSAT:LEVBIO) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Level Bio AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Level Bio AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Level Bio AB (XSAT:LEVBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

LEVBIO:Sweden

Address

Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30

Website

http://www.alphahelix.com

AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines